Because it degrades in blood in a pathway involving amino-peptidases, it may not be suitable for people who take medications that inhibit or are metabolized by peptidases (e.g., captopril, a treatment for hypertension).4 Also, based on what we know about other therapeutic peptides, we would say DSIP is contraindicated for women who are pregnant or breastfeeding as well as people with a personal history of cancer
It is sold as a research reagent and is not FDA-approved for any human use
In addition, injections may be especially beneficial in individuals with gastrointestinal absorption issues
Neuroprotective effects have been observed in certain models of neurological damage
Sometimes, adjusting the dose of tirzepatide or switching to a different therapy is necessary
Consequently, if there is any doubt as to the status of a substance or method, it is important that they contact their respective Anti-Doping Organizations (International Federation or National Anti-Doping Organization) for advice